There are various known molecular aspects in NB, such as MYCN amplification, ALK mutations, chromosomal abnormalities (Carén et al., 2008), changes in the pattern of DNA methylation, and tumor microenvironment (Tonini and Capasso, 2020; Raieli et al., 2021). The gene discussed is ALK; the disease is neuroblastoma.